Literature DB >> 26134832

Modeling the Physiological Factors Affecting Glucose Sensor Function in Vivo.

Matthew T Novak1, William M Reichert2.   

Abstract

For implantable sensors to become a more viable option for continuous glucose monitoring strategies, they must be able to persist in vivo for periods longer than the 3- to 7-day window that is the current industry standard. Recent studies have attributed such limited performance to tissue reactions resulting from implantation. While in vivo biocompatibility studies have provided much in the way of understanding histology surrounding an implanted sensor, little is known about how each constituent of the foreign body response affects sensor function. Due to the ordered composition and geometry of implant-associated tissue reactions, their effects on sensor function may be computationally modeled and analyzed in a way that would be prohibitive using in vivo studies. This review both explains how physiologically accurate computational models of implant-associated tissue reaction can be designed and shows how they have been utilized thus far. Going forward, these in silico models of implanted sensor behavior may soon complement in vivo studies to provide valuable information for improved sensor designs.
© 2015 Diabetes Technology Society.

Entities:  

Keywords:  biocompatibility; biomaterials; biosensors; modeling

Mesh:

Substances:

Year:  2015        PMID: 26134832      PMCID: PMC4667349          DOI: 10.1177/1932296815593094

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  34 in total

1.  Simulations of the frequency response of implantable glucose sensors.

Authors:  M Jablecki; D A Gough
Journal:  Anal Chem       Date:  2000-04-15       Impact factor: 6.986

Review 2.  The intravenous route to blood glucose control.

Authors:  R S Parker; F J Doyle; N A Peppas
Journal:  IEEE Eng Med Biol Mag       Date:  2001 Jan-Feb

3.  A model-based algorithm for blood glucose control in type I diabetic patients.

Authors:  R S Parker; F J Doyle; N A Peppas
Journal:  IEEE Trans Biomed Eng       Date:  1999-02       Impact factor: 4.538

4.  Predicting glucose sensor behavior in blood using transport modeling: relative impacts of protein biofouling and cellular metabolic effects.

Authors:  Matthew T Novak; Fan Yuan; William M Reichert
Journal:  J Diabetes Sci Technol       Date:  2013-11-01

5.  Modeling the relative impact of capsular tissue effects on implanted glucose sensor time lag and signal attenuation.

Authors:  Matthew T Novak; Fan Yuan; William M Reichert
Journal:  Anal Bioanal Chem       Date:  2010-08-28       Impact factor: 4.142

6.  In vitro and in vivo characterization of porous poly-L-lactic acid coatings for subcutaneously implanted glucose sensors.

Authors:  H E Koschwanez; F Y Yap; B Klitzman; W M Reichert
Journal:  J Biomed Mater Res A       Date:  2008-12-01       Impact factor: 4.396

7.  Rat brain microglia and peritoneal macrophages show similar responses to respiratory burst stimulants.

Authors:  A Klegeris; P L McGeer
Journal:  J Neuroimmunol       Date:  1994-08       Impact factor: 3.478

Review 8.  Economic costs of diabetes in the U.S. In 2007.

Authors: 
Journal:  Diabetes Care       Date:  2008-03       Impact factor: 19.112

9.  Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature.

Authors:  M W Dewhirst; C Y Tso; R Oliver; C S Gustafson; T W Secomb; J F Gross
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-07       Impact factor: 7.038

10.  Computational modeling of glucose transport in pancreatic β-cells identifies metabolic thresholds and therapeutic targets in diabetes.

Authors:  Camilla Luni; Jamey D Marth; Francis J Doyle
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

View more
  7 in total

1.  Tissue Response to Subcutaneous Infusion Catheter.

Authors:  Ershuai Zhang; Zhiqiang Cao
Journal:  J Diabetes Sci Technol       Date:  2019-03-31

Review 2.  In Vivo Chemical Sensors: Role of Biocompatibility on Performance and Utility.

Authors:  Robert J Soto; Jackson R Hall; Micah D Brown; James B Taylor; Mark H Schoenfisch
Journal:  Anal Chem       Date:  2016-11-21       Impact factor: 6.986

3.  Glucose Sensing in the Subcutaneous Tissue: Attempting to Correlate the Immune Response with Continuous Glucose Monitoring Accuracy.

Authors:  Jeffrey I Joseph; Gabriella Eisler; David Diaz; Abdurizzagh Khalf; Channy Loeum; Marc C Torjman
Journal:  Diabetes Technol Ther       Date:  2018-05       Impact factor: 6.118

4.  Impact of CCL2 and CCR2 chemokine/receptor deficiencies on macrophage recruitment and continuous glucose monitoring in vivo.

Authors:  Ulrike Klueh; Caroline Czajkowski; Izabela Ludzinska; Yi Qiao; Jackman Frailey; Donald L Kreutzer
Journal:  Biosens Bioelectron       Date:  2016-06-23       Impact factor: 10.618

Review 5.  Continuous Glucose Monitoring Devices: Past, Present, and Future Focus on the History and Evolution of Technological Innovation.

Authors:  Olesya Didyuk; Nicolas Econom; Angelica Guardia; Kelsey Livingston; Ulrike Klueh
Journal:  J Diabetes Sci Technol       Date:  2020-01-13

6.  Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays.

Authors:  P Mason McClatchey; Ethan S McClain; Ian M Williams; Carlo M Malabanan; Freyja D James; Peter C Lord; Justin M Gregory; David E Cliffel; David H Wasserman
Journal:  Diabetes       Date:  2019-08-09       Impact factor: 9.461

7.  A thermal activated and differential self-calibrated flexible epidermal biomicrofluidic device for wearable accurate blood glucose monitoring.

Authors:  Zhihua Pu; Xingguo Zhang; Haixia Yu; Jiaan Tu; Hailong Chen; Yuncong Liu; Xiao Su; Ridong Wang; Lei Zhang; Dachao Li
Journal:  Sci Adv       Date:  2021-01-27       Impact factor: 14.136

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.